Position in ANIK
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$638
New position
Shares Held
44
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GHP Investment Advisors, Inc. holds $7,851,581 across 14 Drug Manufacturers - Specialty & Generic names. ANIK ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
|
88,739 | $5,259,560 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
60,364 | $1,818,163 | |
| 3 | ZTS |
Zoetis Inc.
|
6,239 | $737,512 | |
| 4 | VTRS |
Viatris Inc
|
1,189 | $16,063 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
148 | $11,225 | |
| 6 | HLN |
Haleon plc
|
441 | $4,413 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
21 | $2,766 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
This page
|
44 | $638 |
All Filings in ANIK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $638 | 44 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||